ライフサイエンスコーパス: MRM

1 MRM enabled reproducible, selective detection of the pep

2 MRM has matured to the point that we can generate high c

3 MRM provided again the best results for CV efficiency (8

4 MRM retrieval + ketamine (RET + KET) effectively reduced

5 MRM transitions were established with capability to dist

6 MRM/MS revealed that unlike the rapid, modest (4-fold to

7 .8% [95% CI, 87.2%-98.6%]) and in 154 of 167 MRM-positive infections (92.2% [95% CI, 87.1%-95.8%]).

8 diagnosed from 20 June 2016 to 15 May 2017, MRMs were detected in 167 (68.4% [95% confidence interva

9 h the human genes and miRNAs, predicting 431 MRMs.

10 Microbiologic cure occurred in 73 of 77 MRM-negative infections (94.8% [95% CI, 87.2%-98.6%]) an

11 An MRM method was then established for verification.

12 bility of a large-scale effort to develop an MRM assay resource.

13 we profiled systematically, by employing an MRM-based targeted proteomic method, the differential ex

14 tivity, linearity, and reproducibility of an MRM assay targeting 79 peptides representing 23 human cy

15 ped a high-throughput, SILAC-compatible, and MRM-based kinome profiling method and demonstrated that

16 cin (1 g, then 500 mg daily for 3 days), and MRM-positive infections received sitafloxacin (100 mg tw

17 ugh rapid profiling analyses, such as Q1 and MRM scans.

18 iency are obtained with the use of SIMCA and MRM (82.3 and 83.2% respectively), whereas MRM performs

19 The discriminating potential of the applied MRM approach was confirmed by differences among both 1D

20 By applying MRM to an RRBS dataset from subjects with low versus hig

21 We select these informative ions as MRM transitions for the quantification of the outer arm

22 lated peptides were specifically selected as MRM transitions.

23 s of brain regions; and correlations between MRM and classical histological data sets.

24 nd corpus callosum length can be detected by MRM before Abeta deposition.

25 3beta from whole cell lysate, we discover by MRM-MS a novel O-GlcNAcylated GSK-3beta peptide, bearing

26 ltiple signature peptides can be examined by MRM in a single experiment.

27 liberate the active drug, and quantified by MRM LC-MS/MS.

28 tial proteins were validated respectively by MRM and western blotting quantitative analyses.

29 cycle time from 2.4 s in conventional MRM (c-MRM) to 1 s in s-MRM allowed completion of the EPI scan

30 ic resolution by two endogenously contrasted MRM sequences.

31 total cycle time from 2.4 s in conventional MRM (c-MRM) to 1 s in s-MRM allowed completion of the EP

32 iplexing multiple reaction monitoring cubed (MRM(3)) assay for selective and sensitive quantification

33 ults suggest utility of a multiplex cytokine MRM for routine measurement of secreted cytokines in cel

34 After DI-MRM quantification was evaluated for standards, quantita

35 hods are compared; criteria for effective DI-MRM analysis are reported on the basis of the analysis o

36 Requirements for DI-MRM assay development are described.

37 lectrospray ionization, coupled with MRM (DI-MRM) is used for protein quantification.

38 The increased throughput of DI-MRM analysis is useful for rapid analysis of large batch

39 ins (HSPs) were translated from LC-MRM to DI-MRM for implementation in cell line models of multiple m

40 be comparable with standard isotope dilution MRM MS.

41 pon retrieval - may offer a means to disrupt MRMs and prevent relapse.

42 NMDA) antagonist ketamine is able to disrupt MRMs in hazardous drinkers when administered immediately

43 Directly after doxycycline, MRM-negative infections received 2.5 g azithromycin (1 g

44 n analyte, the s-MRM algorithm monitors each MRM transition only around its expected retention time.

45 e used to determine the significance of each MRM.

46 eaction monitoring mass spectrometry (LC/ESI-MRM-MS) are more commonly used in clinical research.

47 lly long analysis times per sample of LC/ESI-MRM-MS.

48 as well as 8-oxo-dGuo (as measured by LC-ESI/MRM/MS) and was enhanced by a catechol O-methyl transfer

49 eaction monitoring/mass spectrometry (LC-ESI/MRM/MS) assay.

50 predicted beneficial changes only following MRM reactivation.

51 y of a large-scale, international effort for MRM assay generation.

52 on monitoring with multistage fragmentation (MRM(3)) and differential mobility spectrometry (DMS) wer

53 participants, 64.4% (95% CI, 58.2-70.3%) had MRM, 11.5% (95% CI, 7.9-16.0%) had parC mutations, and 0

54 All 11 participants who had MRM detected in posttreatment samples failed azithromyci

55 However, MRM could only detect four peptides (EVTEFAK, LVVITAGAR,

56 The combined integration of fast HPLC, MRM(3), and multiplexing yields an analysis workflow for

57 of plasma free amino acids (PFAA) using HPLC-MRM-Mass spectrometry in relation to presenting symptoms

58 nsitivity than we have obtained by nano HPLC/MRM and substantially better than reported for LC/MS/MS.

59 02 fmol/mug of total protein) between immuno-MRM and immuno-MALDI.

60 suppressor PTEN in Colo-205 cells by immuno-MRM and immuno-MALDI using 2-PIC and external calibratio

61 IC and external calibration: 4.9% for immuno-MRM; 1.1% for immuno-MALDI), without the need for a surr

62 lts demonstrate that high multiplexed immuno-MRM-MS assays are readily achievable using the optimized

63 Although our PTEN immuno-MRM and immuno-MALDI assays can be considered to be orth

64 eaction monitoring-mass spectrometry (immuno-MRM-MS) assay (n = 110) and applied it to measure candid

65 The improved MRM sensitivity described here delivered the highest 3D

66 -humulene were quantified using GC-QQQ-MS in MRM (multiple reaction mode) mode.

67 ximately 5-fold better than that observed in MRM or MIM without DMS.

68 ens of combined hormone contraceptive use in MRM and migraine with aura may decrease both headache fr

69 mass spectrometry (MS) techniques including MRM.

70 The positive ion MRM assay was more than sufficient to quantify endogenou

71 The precursor-to-product ion MRM transitions for alpha-endorphin, gamma-endorphin, an

72 LC-MRM targeted analysis of the two enzymes allowed the dis

73 olorectal cancer cells using MALDI-MS and LC-MRM-MS.

74 Then, a targeted proteomic approach by LC-MRM was used to semi-quantify laccase-2-BcLCC2 and lacca

75 tion of SMPD1 expression was confirmed by LC-MRM-MS analysis and the effect of SMPD1 in drug resistan

76 Having established the parameters for LC-MRM MS, we quantified allergens from various commercial

77 hock proteins (HSPs) were translated from LC-MRM to DI-MRM for implementation in cell line models of

78 ss LC-QTOF MS for semi-polar metabolites, LC-MRM for oxylipins, and headspace GC-MS for volatile comp

79 omatography-multiple-reaction monitoring (LC-MRM) analysis, we also examined the modulation of the AT

80 omatography-multiple reaction monitoring (LC-MRM) mass spectrometric approaches.

81 In this work, we introduce a multiplex LC-MRM assay that simultaneously monitors two high risk lip

82 le reaction monitoring mass spectrometry (LC-MRM MS) for rapid, accurate, and reproducible quantifica

83 le reaction monitoring mass spectrometry (LC-MRM) has emerged as a powerful platform for assessing pa

84 le reaction monitoring mass spectrometry (LC-MRM) was performed to identify differences in apoptosis

85 le reaction monitoring/mass spectrometry (LC-MRM/MS) technique that allows such determinations to be

86 Quantitative data generated from the LC-MRM assay were used to monitor the clearance of these li

87 Our data demonstrate that the LC-MRM MS method is valuable for absolute quantification of

88 The LC-MRM/MS method was rigorously validated using in vitro ki

89 ssion of approximately 300 kinases in two LC-MRM runs.

90 ubjected to relative quantification using LC-MRM-MS.

91 alytical performance to robust, validated LC-MRM methodology for RA quantification.

92 luated and compared to those obtained via LC-MRM and LC-MIM without DMS.

93 LC/MRM-MS can be used to measure all known GCr allergens in

94 The expanded LC/MRM-MS method was optimized to measure known GCr allerge

95 le reaction monitoring mass spectrometry (LC/MRM-MS) assays.

96 ed in a single multiplexed analysis using LC/MRM-MS.

97 ese proof-of-concept experiments using MALDI MRM-based imaging show the feasibility for the precise a

98 d strategy of microbial resource management (MRM).

99 sis on costs of modified radical mastectomy (MRM) compared with breast-conserving surgery (BCS) and r

100 ergone either a modified radical mastectomy (MRM) or a segmental mastectomy with axillary dissection

101 Maladaptive reward memories (MRMs) are involved in the development and maintenance of

102 velop a multiple reaction monitoring method (MRM) to detect the amounts of a particular polymorphism

103 The advent of MR microscopy (MRM) enables imaging biological samples at cellular reso

104 ltiparametric magnetic resonance microscopy (MRM) approach was applied to the Slovenian Kraski prsut

105 potential of magnetic resonance microscopy (MRM) for morphologic phenotyping in the mouse has previo

106 ly, the first magnetic resonance microscopy (MRM) images at the cellular level in isolated mammalian

107 Advances in magnetic resonance microscopy (MRM) make it practical to map gene variants responsible

108 gh-resolution magnetic resonance microscopy (MRM) was used to determine regional brain volumetric cha

109 This approach, termed MIDAS (MRM-initiated detection and sequencing), is more sensiti

110 tions prevents menstrually related migraine (MRM) and migraine aura frequency.

111 e-quadrupole MS-based data acquisition mode (MRM).

112 ng in the multiple reaction monitoring mode (MRM) with collision-induced dissociation.

113 onisation multiple reaction monitoring mode (MRM).

114 selected by multi-reaction monitoring mode (MRM).

115 MS/MS) in multiple reaction monitoring mode (MRM).

116 sites using the mixture of regression model (MRM) of radial basis functions, integrating information

117 he development of the mental rotation model (MRM) and the assertion that response preparation is medi

118 tions (PF), and multivariate range modeling (MRM)) were applied to multielement distribution to build

119 method to predict miRNA regulatory modules (MRMs) or groups of miRNAs and target genes that are beli

120 rometry in the multiple reaction monitoring (MRM) acquisition mode.

121 for scheduled multiple-reaction monitoring (MRM) analysis and adopted on-the-fly recalibration of re

122 ndard prior to multiple reaction monitoring (MRM) analysis enables prefractionation of the target pro

123 etermined with multiple reaction monitoring (MRM) analysis.

124 ding (SIR) and multiple reaction monitoring (MRM) and identified as methylcobalamin (Me-Cbl).

125 [e.g., immuno-multiple reaction monitoring (MRM) and immuno-matrix-assisted laser desorption ionizat

126 Here we take a multiple reaction monitoring (MRM) approach to differentiate and relatively quantify a

127 examined using Multiple Reaction Monitoring (MRM) as the acquisition mode.

128 d to develop a multiple reaction monitoring (MRM) assay that employed stable isotope-labeled peptide

129 ve developed a multiple reaction monitoring (MRM) assay to measure UCH-L1 in the high-speed supernata

130 ed hundreds of multiple reaction monitoring (MRM) assays for isotope ratio mass spectrometry of most

131 Multiple reaction monitoring (MRM) assays have proven successful for the absolute quan

132 tive method of multiple reaction monitoring (MRM) by mass spectrometry.

133 onstrated that multiple reaction monitoring (MRM) coupled with isotope dilution mass spectrometry can

134 efficiency for multiple reaction monitoring (MRM) detection.

135 designing QqQ multiple reaction monitoring (MRM) experiments for each of the 82 696 metabolites in t

136 combination of multiple reaction monitoring (MRM) fragment ratio normalization and chromatographic pe

137 ESI-MS/MS with multiple reaction monitoring (MRM) in the presence of deuterium-labeled internal stand

138 Multiple reaction monitoring (MRM) is a liquid chromatography-mass spectrometry (LC-MS

139 ry (PS-MS) and Multiple Reaction Monitoring (MRM) is described.

140 A rapid multiple reaction monitoring (MRM) mass spectrometric method for the detection and rel

141 uired by MALDI multiple reaction monitoring (MRM) mass spectrometry (MS), and accurate peptide quanti

142 ray ionization multiple reaction monitoring (MRM) mass spectrometry (MS).

143 Multiple reaction monitoring (MRM) mass spectrometry has been successfully applied to

144 Multiple reaction monitoring (MRM) mass spectrometry is a robust method to quantify an

145 ve developed a multiple reaction monitoring (MRM) mass spectrometry method to sensitively quantitate

146 In this study multiple reaction monitoring (MRM) mass spectrometry, viewed as the gold standard for

147 ate peptide by multiple-reaction monitoring (MRM) mass spectrometry.

148 itative LC-QQQ multiple reaction monitoring (MRM) method was developed which allows high-confidence m

149 and to build a multiple reaction monitoring (MRM) method with the MS/MS fragmentation pattern of the

150 hput scheduled multiple-reaction monitoring (MRM) method, along with the use of synthetic stable isot

151 rmed to create multiple reaction monitoring (MRM) methods for a wide range of PXDD/Fs from dihalogena

152 rogresses upon multiple reaction monitoring (MRM) methods, previously used for CK profiling on triple

153 onalized using multiple reaction monitoring (MRM) mode and is able to perform MFA of 310 identified m

154 Multiple reaction monitoring (MRM) mode was used for LC-MS/MS.

155 and DHT in the multiple-reaction monitoring (MRM) mode.

156 S) method with multiple reaction monitoring (MRM) mode.

157 oring (SRM) or multiple reaction monitoring (MRM) modes was developed and employed for imaging of tar

158 Multiple Reaction Monitoring (MRM) of the transition pairs of m/z 449.01 to 371.21 for

159 (LC-MS/MS) by multiple-reaction monitoring (MRM) on a triple quadrupole (QQQ) MS.

160 biosensor and multiple reaction monitoring (MRM) on a triple quadrupole mass spectrometer.

161 stablished for multiple-reaction monitoring (MRM) quantification in serum.

162 atography (LC) multiple reaction monitoring (MRM) quantification methods have necessitated lengthy ch

163 trometry using multiple reaction monitoring (MRM) showed more impressive data, with a 3-fold enrichme

164 We used a multiple reaction monitoring (MRM) to detect (13)C, D2-formaldehyde-modified OSCs by u

165 otocol employs multiple reaction monitoring (MRM) to search for all putative peptides specifically mo

166 own masses, or multiple reaction monitoring (MRM) transitions and are therefore often unable to detec

167 in 4 min using multiple reaction monitoring (MRM) transitions selective for each compound.

168 corresponding multiple reaction monitoring (MRM) transitions, and negative ions were approximately 1

169 Multiple reaction monitoring (MRM) was applied and the selection of proper product ion

170 ry method with multiple reaction monitoring (MRM) was employed to measure 264 lipid analytes extracte

171 e ion mode and multiple reaction monitoring (MRM) were used for LC-MS/MS.

172 Multiple reaction monitoring (MRM) with optimised transitions and collision energies f

173 quantified by multiple reaction monitoring (MRM), a mass spectrometry-based quantification method.

174 de (Cer) using Multiple Reaction Monitoring (MRM), as they play a vital role in drug resistance.

175 the method of multiple reaction monitoring (MRM), we precisely and quantitatively measured the absol

176 s suitable for multiple reaction monitoring (MRM)-based analysis and spanning positions 30-51, 61-112

177 ng predictable multiple reaction monitoring (MRM)-based quantitation with improved sensitivity.

178 hput scheduled multiple-reaction monitoring (MRM)-based targeted proteomic approach to quantify syste

179 established a multiple-reaction monitoring (MRM)-based targeted proteomic method that provided an un

180 igh-throughput multiple-reaction monitoring (MRM)-based workflow together with stable isotope labelin

181 hieved by UPLC/multiple-reaction monitoring (MRM)-MS, with analytical accuracies ranging from 87.4% t

182 d detection by multiple reaction monitoring (MRM).

183 eveloped using multiple reaction monitoring (MRM).

184 negative-mode multiple reaction monitoring (MRM).

185 mixture using multiple-reaction monitoring (MRM).

186 ying scheduled multiple reaction monitoring (MRM).

187 orkflow, using multiple reaction monitoring (MRM).

188 the lysosome, multiple reaction monitoring (MRM)/mass spectrometry (MS) and polyubiquitin linkage-sp

189 trometry using multiple-reaction-monitoring (MRM) mode, with a lower limit of quantitation at 1.00 nM

190 d neutral-loss multiple-reaction-monitoring (MRM), and high-resolution mass spectrometry.

191 h to optimize multiple reactions monitoring (MRM) analysis and to confirm chromatographic retention t

192 activated carbon (AC); CETCO Organoclay MRM (MRM); Thiol-SAMMS (TS), a thiol-functionalized mesoporou

193 metry multiple reaction monitoring (LC-MS/MS MRM) assay.

194 Glycosidase assisted LC-MS-MRM analysis of individual patient samples prepared by a

195 we developed a sensitive and specific LC-MS-MRM quantification method that distinguishes the outer a

196 h multiple reaction monitoring (LC-ESI-MS/MS-MRM) to simultaneously measure levels of 5 mC and 5 hmC

197 mmary, we have established a multiplex LC/MS/MRM method for quantitatively profiling hundreds of know

198 acids), are sequentially analyzed on a LC/MS/MRM system.

199 detection and quantification of multiplexed, MRM-based assays, conducted by NCI-CPTAC.

200 The fast HPLC multiplexing MRM(3) assay demonstrated enhanced selectivity for endog

201 assessed for macrolide resistance mutations (MRMs) by high-resolution melt analysis.

202 nitalium and macrolide-resistance mutations (MRMs) by polymerase chain reaction.

203 (macrolide resistance-associated mutations [MRMs]) and in parC and gyrA (quinolone-associated mutati

204 mined by LC-Triple Quadrupole MS in negative MRM mode using external standard calibration.

205 ble as a resource to the community 645 novel MRM assays representing 319 proteins expressed in human

206 We report the ability of MRM-MS to detect a standard O-GlcNAcylated peptide and s

207 results of a systematic genetic analysis of MRM data using as a case study a family of well characte

208 nd computational methods for the analysis of MRM-MS data from proteins and peptides are still being d

209 Our results demonstrate the applicability of MRM for identification of HMPV, and assignment of geneti

210 The potential of MRM analysis for the quantification of specific host cel

211 quantitation is determined from the ratio of MRM transitions for the endogenous unlabeled proteolytic

212 libration curves relating the area ratios of MRM signals from polymorphism-containing peptides to app

213 The use of ratios of MRM transition peak areas for corresponding peptides is

214 he remarkable sensitivity and selectivity of MRM enable the detection of low abundance IgG glycopepti

215 tyrosine in a PD model and the first use of MRM mass spectrometry to quantify changes in 3NT modific

216 While the use of MRM-MS assays is well established in the small molecule

217 SRM or MRM modes were employed to avoid artifacts that are pres

218 organized in precursor/product ion pairs, or MRMs, and the screening stage rapidly interrogates indiv

219 : an activated carbon (AC); CETCO Organoclay MRM (MRM); Thiol-SAMMS (TS), a thiol-functionalized meso

220 Our MRM method was able to identify 21 cytokines by two or m

221 Our MRM strategy, based on the application of successive, tr

222 A targeted multiplexed peptide MRM LC-MS/MS assay was used on a larger validation cohor

223 In this study, we performed MRM-Profiling of lipid extracts from four different stra

224 Positive MRMs trigger an MS/MS experiment to confirm the nature a

225 ositive/MRM-positive men, 13% of MG-positive/MRM-negative men, and 17.2% of MG-negative men.

226 mptoms were reported by 25.8% of MG-positive/MRM-positive men, 13% of MG-positive/MRM-negative men, a

227 Pretreatment MRM was detected in 56 (36% [95% CI, 28%-43%]) participa

228 ids, multiple reaction monitoring profiling (MRM-Profiling) has been applied.

229 With a quantitative MRM proteomic analysis of neuronal Gbeta and Ggamma subu

230 Here we review MRM capabilities and image segmentation methods; heritab

231 on (IDA) functionality was used to combine s-MRM with enhanced product ion (EPI) scans within the sam

232 .4 s in conventional MRM (c-MRM) to 1 s in s-MRM allowed completion of the EPI scan at the same time.

233 a scheduled multiple reaction monitoring (s-MRM) algorithm.

234 a known retention time of an analyte, the s-MRM algorithm monitors each MRM transition only around i

235 by selected/multiple reaction monitoring (S/MRM) or, on a larger scale, by SWATH (sequential window

236 ated with future work to develop large-scale MRM experiments.

237 Scheduled MRM improved the quality of the chromatograms, signal re

238 UPLC/scheduled MRM-MS with negative ion electrospray ionization enabled

239 a Multiple Reaction Monitoring method (Scout-MRM) where the use of spiked scout peptides triggers com

240 The interest of Scout-MRM method regarding the retention time independency, mu

241 with NGP-based stable-isotope-labeled (SID)-MRM in the individual samples of 38 HCC serum and 24 nor

242 xperience with analyzing a wide range of SID-MRM-MS data, we set forth a methodology for analysis tha

243 e reaction monitoring mass spectrometry (SIL/MRM-MS) has been frequently used to measure low-abundanc

244 immunoprecipitation in conjunction with SIL/MRM-MS assay which is capable of sensitive and accurate

245 However, the applicability of a single MRM method to many commercial foods is unknown as comple

246 Isomer-specific MRM transitions allowed effective differentiation of neu

247 tiple reaction monitoring mass spectrometry (MRM MS) with (15)N-labeled full-length apoE4 as an inter

248 tiple reaction monitoring mass spectrometry (MRM-MS) analysis of the nonglycopeptides, the assay can

249 tiple reaction monitoring mass spectrometry (MRM-MS) assays that detected M. tuberculosis peptides in

250 tiple reaction monitoring mass spectrometry (MRM-MS) with stable isotope dilution (SID) is increasing

251 tiple Reaction Monitoring Mass Spectrometry (MRM-MS), a targeted MS method, to detect and quantify na

252 tiple reaction monitoring mass spectrometry (MRM-MS), and the resultant candidate biomarkers were the

253 tiple reaction monitoring mass spectrometry (MRM-MS).

254 pplicability of the novel ambient LARESI SRM/MRM MSI method to both investigating and discovering can

255 n selected/multiple reaction monitoring (SRM/MRM) mass spectrometry into the clinical laboratory to f

256 d in all fortified samples, a challenge that MRM-transition could not address in a single step.

257 The results demonstrate that MRM-Profiling distinguishes the lipid profiles of resist

258 We found that MRM can be used to image single myofibers with 6-mum res

259 the MRM and furosine results indicated that MRM based on tryptic digests of whole products was a fea

260 Recent studies continue to support that MRM is precipitated by drops in estrogen concentrations,

261 The MRM method was developed from a knowledge of peptide fra

262 The MRM results showed an increase in peak areas of the two

263 The MRM UHPLC-MS/MS method, Western blot and RT-PCR were use

264 The MRM-Profiling workflow includes a discovery stage and a

265 A good correlation between the MRM and furosine results indicated that MRM based on try

266 stern blot analysis further corroborated the MRM quantification results for selected small GTPases.

267 To determine if the MRM can be extrapolated to perceptually familiar angles

268 e data-dependent acquisition (DDA) mode, the MRM-based proteomic platform substantially increased the

269 on was common among men with urethritis; the MRM prevalence was high among men with MG.

270 Consistent with the MRM, experiment one revealed a linear increase in RT as

271 ly interrogates individual samples for these MRMs.

272 We subsequently optimized this MRM-MS assay to selectively identify 40 M. tuberculosis

273 Rasa Aragonesa sheep was analyzed using this MRM method.

274 The combination of high throughput MRM and genomics will improve our understanding of the g

275 SWATH-MS was comparable (p < 0.001) to MRM-MS for 32/33 peptides assessed across the four famil

276 At least two MRM transitions were used to quantify and identify each

277 onventional approach with LC-MS/MS using two MRM transitions produced the same identifications and co

278 mes the sensitivity challenge in the typical MRM method due to poor CID fragmentation of the analyte.

279 live oil have been assayed by LC-MS/MS under MRM condition and isotope dilution method, using d(2)-la

280 a products and drugs based on PS-MS/MS under MRM condition has been developed.

281 compensate for over recovery observed under MRM-transition mode.

282 The assay has been performed under MRM condition monitoring two transitions for each analyt

283 stically different than for women undergoing MRM.

284 ere eligible for our study; 44 had undergone MRM, and 50 had undergone SegAx/XRT.

285 nt ion transitions were used to perform UPLC-MRM-MS for untargeted detection of the structural isomer

286 -reaction monitoring-mass spectrometry (UPLC-MRM-MS) method for the separation and detection of 50 kn

287 In summary, this UPLC-MRM-MS method has enabled the quantitation of the larges

288 We used MRM to obtain 3D volumetric data on mouse brains imaged

289 The limits of detection (S/N =3) using MRM are 20 pg for Ang IV and 25 pg for Ang 1-7, Ang III,

290 We have developed a method using MRM to monitor protein glycosylation normalized to absol

291 ation of target peptides was performed using MRM on a LC/triple-quad MS/MS using (12)C- (control) and

292 ivity and accuracy of the quantitation using MRM were determined, with the detection limit in the fem

293 nowledge, this is the first report utilizing MRM-MS to detect native O-GlcNAc modified peptides.

294 liable means for pharmacologically weakening MRMs in humans remain elusive.

295 d MRM (82.3 and 83.2% respectively), whereas MRM performs better than SIMCA in terms of forced model

296 decreased background signal associated with MRM.

297 o generate reproducible data comparable with MRM-MS, but has the added benefits of allowing reinterro

298 ed nanoelectrospray ionization, coupled with MRM (DI-MRM) is used for protein quantification.

299 pic and quantotypic peptides to proceed with MRM method development.

300 ly $450 per month higher than for women with MRM.